Interstitial lung disease and gefitinib.

MLA

Murashige N, et al. “Interstitial Lung Disease and Gefitinib.” New England Journal of Medicine, vol. 363, no. 16, Oct. 2010, pp. 1578–80. EBSCOhost, https://doi.org/10.1056/NEJMc1008506.

APA

Murashige N, Tanimoto T, Oshima Y, Murashige, N., Tanimoto, T., & Oshima, Y. (2010). Interstitial lung disease and gefitinib. New England Journal of Medicine, 363(16), 1578–1580. https://doi.org/10.1056/NEJMc1008506

Chicago

Murashige N, Tanimoto T, Oshima Y, Naoko Murashige, Tetsuya Tanimoto, and Yasuo Oshima. 2010. “Interstitial Lung Disease and Gefitinib.” New England Journal of Medicine 363 (16): 1578–80. doi:10.1056/NEJMc1008506.